Metabolic
3 drugs are in development for Osteoporosis.
- Companies
- 3
- Clinical trials
- 17
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Osteoporosis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| microcor hpth | Corium International, Inc. (CORI) |
Phase 1(1)
| Drug | Company |
|---|---|
| rt-102 | Rani Therapeutics Holdings, Inc. (RANI) |
BLA Filed(1)
| Drug | Company |
|---|---|
| pf708 | Pfenex Inc. (PFNX) |
About this indication
Osteoporosis context
Metabolic·MeSH: Osteoporosis (D010024)
Also known as: Osteoporoses
Prevalence
7000.0 / 100K
Incidence
300.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Osteoporosis?
BioSniper tracks 3 drugs in development for Osteoporosis across 3 companies.
How many clinical trials target Osteoporosis?
There are 17 clinical trials targeting Osteoporosis tracked by BioSniper.
What is the prevalence of Osteoporosis?
The estimated prevalence of Osteoporosis is approximately 7000.0 per 100,000 population.